Tvardi Therapeutics (TVRD) Net Equity Issued and Repurchased (2015 - 2023)
Tvardi Therapeutics (TVRD) posted Net Equity Issued and Repurchased of $1.1 million for Q3 2023, down 99.18% sequentially from $136.5 million in Q3 2019.
Tvardi Therapeutics (TVRD) Net Equity Issued and Repurchased (2015 - 2023) Analysis & Trends
Tvardi Therapeutics has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $1.1 million in Q3 2023.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1.1 million in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $137.6 million (changed N/A YoY) and the FY2023 annual result came in at $1.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased declined to $1.1 million in Q3 2023 per TVRD's latest filing, from $136.5 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $136.5 million in Q3 2019 and troughed at $1.1 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Sep 30, 2019 | 136.53 Mn |
| Sep 30, 2019 | 136.53 Mn |
| Dec 31, 2018 | -14,000.00 |
| Dec 31, 2018 | -14,000.00 |
| Dec 31, 2015 | -222,000.00 |
| Dec 31, 2015 | -222,000.00 |